ClinicalTrials.Veeva

Menu

Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis (DIAGNON)

V

Vilnius University

Status

Unknown

Conditions

Acute Pancreatitis

Treatments

Diagnostic Test: CT Scan Day 5-7

Study type

Observational

Funder types

Other

Identifiers

NCT03634787
158200-17-941-455

Details and patient eligibility

About

To investigate the role of Heat Shock Proteins in the mechanism of acute severe pancreatitis. In addition to test the potential treatment target of acute pancreatitis.

All patients who present with clinical symptoms of acute pancreatitis are evaluated for the enrollment of the study.

Full description

All patients with acute pancreatitis are evaluated according to modified Atlanta classification acute pancreatitis severity scores.

Blood serum, urine and DNA samples are collected from all patients presented on admission, after 24 hours, 48 hours, 72 hours.

CT is performed in al patients to evaluate necrosis of pancreas Day 5-7 since hospital admission. If necrosis is not present follow-up is stopped.

Enrollment

280 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • no prior diagnosis of acute pancreatitis
  • admission to the hospital within 2 days since the clinical symptoms
  • confirmed diagnosis of acute pancreatitis

Exclusion criteria

  • chronic pancreatitis
  • pancreatic cancer

Trial design

280 participants in 2 patient groups

Acute pancreatitis
Description:
First time acute pancreatitis. No later than 2 days since the clinical symptoms started.
Treatment:
Diagnostic Test: CT Scan Day 5-7
Healthy
Description:
No major systemic illness

Trial contacts and locations

1

Loading...

Central trial contact

Kestutis Strupas, Prof. MD/PhD; Aiste Gulla, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems